respiratory
COPD

Low dose morphine now indicated for chronic breathlessness


Low dose morphine capsules have been licensed by the TGA for the treatment of chronic breathlessness. The re-purposing of Kapanol sustained-release capsules (10mg and 20mg) from use in chronic pain to chronic breathlessness has been welcomed by palliative care specialist Professor David Currow, who was Chief Investigator in the Palliative Care Clinical Studies Collaborative (PaCCSC) ...

Already a member?

Login to keep reading.


OR
© 2019 the limbic